Providence Cancer Center

Southfield, Michigan 48075

We've found

1 trials

at this facility

A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Southfield, MI

Use our guide to learn which trials are right for you!